Updates are available Correction dated 2025-04-16
Click to view Correction: https://doi.org/10.1038/s43018-025-00967-6
-
Authors
Kim, Won Seog https://orcid.org/0000-0002-5400-0466
Kim, Tae Min https://orcid.org/0000-0001-6145-4426
Cho, Seok-Goo
Jarque, Isidro
Iskierka-Jażdżewska, Elżbieta
Poon, Li Mei
Prince, H. Miles https://orcid.org/0000-0002-0058-2448
Zhang, Huilai
Cao, Junning
Zhang, Mingzhi
Tessoulin, Benoît
Oh, Sung Yong
Lim, Francesca
Carpio, Cecilia
Tan, Tran-Der
Ayyappan, Sabarish
Gutierrez, Antonio
Cai, Jingxian
Ufkin, Melanie
Shariff, Saleem
Brouwer-Visser, Jurriaan
Chaudhry, Aafia
Mohamed, Hesham
Ambati, Srikanth
Walewski, Jan
,
Rose, Hannah
Chong, Geoffrey
Ganju, Vinod
Chu, Michael
Keating, Mary-Margaret
Song, Yuqin
Zhu, Jun
Ke, Xiaoyan
Yi, Shuhua
Zhang, Huilai
Zhang, Qingyuan
Zou, Liqun
Zhang, Mingzhi
Li, Dengju
Qian, Wenbin
Bai, Ou
Gao, Li
Jin, Jie
Li, Caixia
Huang, Huiqiang
Wei, Zheng
Chen, Youhua
He, Pengcheng
Damaj, Gandhi Laurent
Bouabdballah, Kamal
Bachy, Emmanuel
Haioun, Corinne
Morschhauser, Franck
Choquet, Sylvain
Delwail, Vincent
Thieblemont, Catherine
Duell, Johannes
Weber, Thomas
La Rosee, Paul Graf
Hebart, Holger
Capochiani, Enrico
Zilioli, Vittorio
Rossi, Francesca
Luminari, Stefano
Zinzani, Pier Luigi
Bagnato, Laura
Gaidano, Gianluca
Brociner, Marco
Skert, Cristina
Tani, Monica
Battistini, Roberta
Flenghi, Leonardo
Yamamoto, Ryusuke
Tsukasaki, Kunihiro
Ishizawa, Kenichi
Tobai, Tomomi
Uchida, Toshiki
Minami, Yosuke
Yamauchi, Nobuhiko
Yuda, Junichiro
Takeuchi, Masahiro
Nagai, Hirokazu
Suehiro, Youko
Ogawa, Yoshiaki
Kuroda, Junya
Jo, Tatsuro
Nakamae, Hirohisa
Yoshida, Isao
Taszner, Michal
Lech-Maranda, Ewa
Knopinska-Posluszny, Wanda
Wrobel, Tomasz
Robak, Tadeusz
Hsieh, Wen Son
Ong, Shin Yeu
Eom, Hyeon-Seok
Mun, Yeung-Chul
Rok Do, Young
Kim, Jin Seok
Kim, Byung Soo
Jo, Jae-Cheol
Jimenez-Ubieto, Ana
Andreu, Rafael
Martin, Alejandro
Coello, Agustin Penedo
Cordoba, Raul
Alonso, Aranzazu
Magnano, Laura
Gonzalez-Barca, Eva
Miqueleiz, Sara
Chen, Tsai Yun
Yeh, Su Peng
Wu, Shang-Ju
Wang, Ming-Chung
Cunningham, David
Kuhnl, Andrea
Tucker, David
Lewis, David
Elmusharaf, Nagah
Allan, John
Jandl, Thomas
Ibrahimi, Sami
Jagadeesh, Deepa
Leslie, Lori
Venugopal, Parameswaran
Arnason, Jon
Villasboas, Jose C.
Vaidya, Rakhee
Stevens, Don
Awan, Farrukh
Klein, Andreas
Farooq, Umar
-
Funding
Funding for this research was provided by:
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 23 January 2025
First Online: 17 March 2025
Change Date: 16 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43018-025-00967-6
Competing interests
: W.S.K. reports research funding from BeiGene, Boryung, Donga, Kyowa-Kirin, Roche and Sanofi. T.M.K. reports honoraria from Amgen, AstraZeneca, IMBDx, Janssen, MedImmune and Takeda, trial research funding to institution from AstraZeneca, consultancy for AstraZeneca, Boryung, F.Hoffmann-La Roche, Janssen, MedImmune, Novartis, Regeneron Pharmaceuticals, Inc., Roche, Samsung Bioepis, Takeda and Yuhan, speaker bureau fees for IMBDx, Janssen and Takeda, membership on an entity’s board of directors or advisory committees for BeiGene, Janssen, Novartis, Regeneron Pharmaceuticals, Inc., Roche and Takeda and an uncompensated relationship with AstraZeneca, Boryung, MedImmune, Novartis and Roche. I.J. reports consultancy for Amgen, AstraZeneca, Kyowa-Kirin, Novartis, Pfizer, Sobi and Takeda, research funding from Amgen, AstraZeneca, BeiGene, Incyte, Janssen, Regeneron Pharmaceuticals, Inc., Sobi and Takeda and honoraria fees from AstraZeneca, Incyte, Janssen, Novartis, Pfizer, Sobi and Takeda. E.I.-J. reports consultancy for AbbVie and AstraZeneca and honoraria from AbbVie, AstraZeneca, Janssen and Novartis. L.M.P. reports research funding from Regeneron Pharmaceuticals, Inc. B.T. reports honoraria from AbbVie, Gilead, Incyte and Kite. C.C. reports honoraria from Gilead, Novartis, Regeneron Pharmaceuticals, Inc. and Takeda, consultancy for BMS, Regeneron Pharmaceuticals, Inc. and Takeda and membership on an entity’s board of directors or advisory committees for Regeneron Pharmaceuticals, Inc. and Takeda. Sa.A. reports membership on an entity’s board of directors or advisory committee for AbbVie, AstraZeneca, BeiGene, Fate Therapeutics and Regeneron Pharmaceuticals, Inc., consultancy for ADC Therapeutics and AstraZeneca and speaker bureau fees from BeiGene and Genentech. J. Cai, M.U., S.S., J.B.-V., A.C., H.M. and S. Ambati hold stock or stock options for and are employees of Regeneron Pharmaceuticals, Inc. J.W. reports consultancy for AbbVie, Gilead, Novartis, Roche, Takeda and MSD, research or clinical trial funding from GSK, Novartis and Roche and honoraria from AbbVie, Amgen, Gilead, GSK, Novartis, Roche and Takeda. The other authors declare no competing interests.
